Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOLUTEGRAVIR Cause Hyperglycaemia? 172 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 172 reports of Hyperglycaemia have been filed in association with DOLUTEGRAVIR (Juluca). This represents 1.6% of all adverse event reports for DOLUTEGRAVIR.

172
Reports of Hyperglycaemia with DOLUTEGRAVIR
1.6%
of all DOLUTEGRAVIR reports
0
Deaths
38
Hospitalizations

How Dangerous Is Hyperglycaemia From DOLUTEGRAVIR?

Of the 172 reports, 38 (22.1%) required hospitalization, and 11 (6.4%) were considered life-threatening.

Is Hyperglycaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DOLUTEGRAVIR. However, 172 reports have been filed with the FAERS database.

What Other Side Effects Does DOLUTEGRAVIR Cause?

Foetal exposure during pregnancy (1,036) Exposure during pregnancy (776) Virologic failure (770) Pathogen resistance (586) Maternal exposure during pregnancy (517) Viral mutation identified (510) Treatment failure (453) Drug ineffective (447) Off label use (413) Blood hiv rna increased (410)

What Other Drugs Cause Hyperglycaemia?

INSULIN GLARGINE (1,903) METFORMIN (1,626) ALPELISIB (1,575) DEXAMETHASONE (1,169) PREDNISONE (1,135) INSULIN LISPRO (743) PREDNISOLONE (705) INSULIN ASPART (646) INSULIN HUMAN (620) METHYLPREDNISOLONE (604)

Which DOLUTEGRAVIR Alternatives Have Lower Hyperglycaemia Risk?

DOLUTEGRAVIR vs DOLUTEGRAVIR\LAMIVUDINE DOLUTEGRAVIR vs DOLUTEGRAVIR\LAMIVUDINE\TENOFOVIR DISOPROXIL DOLUTEGRAVIR vs DOLUTEGRAVIR\RILPIVIRINE DOLUTEGRAVIR vs DOMPERIDONE DOLUTEGRAVIR vs DOMPERIDONE\PANTOPRAZOLE

Related Pages

DOLUTEGRAVIR Full Profile All Hyperglycaemia Reports All Drugs Causing Hyperglycaemia DOLUTEGRAVIR Demographics